Grow Your Wealth
with Mutual Funds
ICICI Prudential Nifty Pharma Index Fund Direct-growth
Equity
Large Cap
Very High Risk
Latest AUM
₹ 104.7 Cr.
NAV as on 27 jul, 2026
₹ 20.10
+20.58%
3 years annulised
This Fund
Fund Details
Fund Names
ICICI Prudential Nifty Pharma Index Fund Direct-growth
Inception Date
14 Dec 2022
Lock In
No Lock-in
Risk
Principal at very high risk
Category Average Annual Returns
6.04
Portfolio Composition Analysis
Equity
99.94%
Cash
0.06%
Portfolio Updated on: 09 Jul, 2026
Sector Allocations
Equity
Healthcare
Portfolio Updated on: 27 jul, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 22.89% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 23.17% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 21.81% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 22.05% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 22.18% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 22.18% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 21.38% |
Debt & Credit Risk Analysis
| Alpha | -1.14% |
| Beta | 0.96% |
| Sharpe Ratio | 0.94% |
| Standard Deviation | 16.81% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 12.16% | NA | 6.12% |
| 6 Months | 19.39% | NA | 12.92% |
| 9 Months | 16.48% | NA | 4.47% |
| 1 Year | 14.49% | 14.49% | 6.04% |
| 2 Years | 20.63% | 9.83% | 24.93% |
| 3 Years | 73.88% | 20.25% | 25.71% |
ICICI Prudential Nifty Pharma Index Fund Direct-growth is one Equity mutual fund offered by ICICI Prudential Mutual Fund. Launched on 14 Dec 2022, the fund aims Long term wealth creation solution. An index fund that seeks to track returns by investing in a basket of Nifty Pharma Index stocks and aims to achieve returns of the stated index, subject to tracking error. It manages assets worth ₹104.7 crore as on Tue Mar 31, 2026. The expense ratio stands at 0.38%.
Ashwini Shinde has experience Prior to Joining the ICICI Pru Mutual Fund he has worked with ICICI Pru AMC Treasury Mutual Fund Operations,
Kayzad Eghlim has experience Prior to joining ICICI Prudential AMC he has worked with IDFC Investment Advisors Ltd., Prime Securities and Canara Robeco Mutual Fund.
Nishit Patel has experience Prior to joining ICICI Prudential Mutual fund, he has worked with K.K.Dand & Co.
Top Performing Mutual Funds
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from ICICI Prudential Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +1.81% | +9.15% | +16.35% | +6.18% | +23.07% | +15.99% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +1.81% | +9.15% | +16.35% | +6.18% | +23.07% | +15.99% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| ICICI Prudential Nifty Healthcare Etf-growth | 157.4 | +3.36% | +10.66% | +18.53% | +11.33% | +20.43% | +14.08% |
| ICICI Prudential Nifty Pharma Index Fund-growth | 104.7 | +4.00% | +11.98% | +19.00% | +13.77% | +19.50% | — |
| ICICI Prudential Nifty Pharma Index Fund-idcw | 104.7 | +4.00% | +11.98% | +19.00% | +13.77% | +19.50% | — |
| ICICI Prudential Nifty Pharma Index Fund Direct-idcw | 104.7 | +4.07% | +12.16% | +19.39% | +14.49% | +20.25% | — |
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund-growth | 7,898.2 | +2.37% | +8.92% | +15.97% | +6.41% | +18.28% | +12.99% |
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +2.37% | +8.92% | +15.97% | +6.41% | +18.28% | +12.99% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.44% | +9.15% | +16.47% | +7.36% | +19.35% | +14.01% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +1.81% | +9.15% | +16.35% | +6.18% | +23.07% | +15.99% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +1.88% | +9.37% | +16.82% | +7.07% | +24.11% | +17.02% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +1.81% | +9.15% | +16.35% | +6.18% | +23.07% | +15.99% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹585.48 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹585.48 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹406.78 | +23.82% | +18.25% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹406.78 | +23.82% | +18.25% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹47.15 | +24.11% | +17.02% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹28.47 | +24.11% | +17.02% | — |
| Sbi Healthcare Opportunities Fund-growth | ₹506.05 | +22.55% | +17.02% | — |
| Sbi Healthcare Opportunities Fund-idcw | ₹318.78 | +22.55% | +17.02% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹50.72 | +23.36% | +16.17% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹30.55 | +23.36% | +16.17% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 27 Jul 2026 | ₹20.10 |
| 24 Jul 2026 | ₹19.79 |
| 23 Jul 2026 | ₹19.86 |
| 22 Jul 2026 | ₹19.94 |
| 21 Jul 2026 | ₹20.20 |
| 20 Jul 2026 | ₹20.13 |
| 17 Jul 2026 | ₹19.85 |
| 16 Jul 2026 | ₹20.13 |
| 15 Jul 2026 | ₹20.12 |
| 14 Jul 2026 | ₹20.05 |
| 13 Jul 2026 | ₹19.85 |
| 10 Jul 2026 | ₹19.87 |
| 09 Jul 2026 | ₹19.85 |
| 08 Jul 2026 | ₹19.67 |
| 07 Jul 2026 | ₹19.87 |
| 06 Jul 2026 | ₹20.00 |
| 03 Jul 2026 | ₹19.91 |
| 02 Jul 2026 | ₹19.57 |
| 01 Jul 2026 | ₹19.47 |
| 30 Jun 2026 | ₹19.58 |
| 29 Jun 2026 | ₹19.51 |
| 25 Jun 2026 | ₹19.31 |
| 24 Jun 2026 | ₹19.35 |
| 23 Jun 2026 | ₹19.33 |
| 22 Jun 2026 | ₹19.15 |
| 19 Jun 2026 | ₹18.92 |
| 18 Jun 2026 | ₹18.78 |
| 17 Jun 2026 | ₹18.68 |
| 15 Jun 2026 | ₹18.73 |
| 12 Jun 2026 | ₹18.86 |
Portfolio Updated on: 28 Jul, 2026
Fund Growth & Size Analysis
+₹104.7 Cr
Since Launch
This Fund
Category Average
Compare Mutual funds
ICICI Prudential Nifty Pharma Index Fund Direct-growth Returns Comparison
Compare ICICI Prudential Nifty Pharma Index Fund Direct-growth with any MF,
EYF, stock or index
Jan 1, 2026 – Feb 1, 2026
ICICI Prudential Nifty....
No funds found for your search.
ICICI Prudential Nifty Pharma Index Fund Direct-growth FAQ'S
- Sharpe Ratio: 0.94%
- Standard Deviation: 16.81%
- Beta: 0.96%
- Alpha: -1.14%
Additional important ratios:
As of Tue Mar 31, 2026, the total assets managed under ICICI Prudential Nifty Pharma Index Fund Direct-growth stand at approximately ₹ 104.7 crore.
The ICICI Prudential Nifty Pharma Index Fund Direct-growth has delivered the following short-term performance:
- 3 Months Return: 12.16%
- 6 Months Return: 19.39%
The historical growth of the ICICI Prudential Nifty Pharma Index Fund Direct-growth is reflected through its CAGR returns:
- 3 Year CAGR: 20.25%
- Return Since Launch: 21.27%
The portfolio of ICICI Prudential Nifty Pharma Index Fund Direct-growth is distributed across different asset classes as follows:
- Equity: 99.94%
- Other Assets: 0.06%
The ICICI Prudential Nifty Pharma Index Fund Direct-growth is managed by Nishit Patel, representing ICICI Prudential Mutual Fund.
The ICICI Prudential Nifty Pharma Index Fund Direct-growth investments are allocated across market caps in the following manner:
- Large Cap Stocks: 1.00%
- Mid Cap Stocks: 1.00%
- Small Cap Stocks: 1.00%
Top stock holdings of ICICI Prudential Nifty Pharma Index Fund Direct-growth include:
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 22.89% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 23.17% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 21.81% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 22.05% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 22.18% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 22.18% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 21.38% of the portfolio
Major sector exposures in ICICI Prudential Nifty Pharma Index Fund Direct-growth are:
- Healthcare – accounts for 959.30% of the portfolio
